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THTS is the third of a series ofreports on anexperiment in which I mg. methyl-
cholanthrene in 0-I c.c. sesame oil was injected subcutaneously into the right
flank of a number of two-months-old mice, belonging to the inbred strain's CBA
and NBT and to 10 inbred generations of their reciprocal hybrids beginning with
F,. A further 2 generations of untreated hybrids were raised, and the controls
were the corresponding 12 generations of untreated mice of the same descent,
originating from the untreated F, litter-mates of the injected hybrids as already
described (Miller and Pybus, 1954a). In both groups of injected hybrids there
were some litters from F. onwards which were not injected and not bred from;
these served as further controls. The reciprocal hybrids were named the CBA/
NBT or CN, and the NBT/CBA or NC strains; the prefix M was used to denote
the injected groups and the uninjected descendants of injected mice. After
injection, the mice of each pure strain were bred from, for one generation only, to
give the M/NBT F, and M/CBA F,. groups, this generation remaining untreated.
During the period of the experiment there were available as pure strain controls
254 females and 295 males of the CBA strain, and 309 females and 363 males of
the NBT strain.
At one time the incidence of sporadic mammary tumours in the CBA strain
was about 5 per cent, butlatterly had declined. The NBTmice, although derived
from the high mammary tumour Simpson strain, had never had a high incidence
of breast cancer and had produced no case since the seventeenth generation; NBT mice from Generations 28 and 29 were used as parents of the hybrids, and
mice from Generations 28 to 30 wereinjected, in the present experiment. During the period of the experiment no mammary tumours appeared in the untreated
mice of either inbred strain. Both inbred strains were believed to lack the milk
factor, but had been proved to be susceptible to its influence (Miller and Pybus,
1944) 1945). The origin of the mice used in the present work was given in detail
in aprevious communication (Miller andPybus, 1954a).
Throughout this paper, the word "tumour" without qualification denotes
cc mammary tumour
" and the incidences are based in all cases on the effective
numbers ofmice, i.e. the numbers alive in each group at the time ofdiscovery of
the earliest mammary tumour in that group. As will be seen from the various
tables, many mice in all groups and especially in the injected groups died before
reaching tumour age. "Tumour age
" is subject to the qualification mentioned
in the previous communications (Mfller and Pybus, 1954a and 1954b) since,
although a superficial tuniour, the neoplasm could not be identified for certain
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until the mouse was killed and the tumour sectioned; mice were allowed to hve
as long as possible in order that remote effects of the carcinogen might be dis-
covered. Owing to the large numbers of mice in the experiment, tumours,
especially in later generations, were charted-only at death instead of at their first
appearance, but the rrn'ce of all groups were equally subject to this error, and the
tumour ages
" in the different groups are therefore legitimately comparable and
are an indication of the relative susceptibilities of the different groups.
Since this paper deals with mammary tumours, and no instance of a male
mouse with this t e of tumour occurred during the experiment, the numbers
of mice given refer oDly to females.
RESULTS.
Pure strains.-There were no tumours in the treated M/CBA mice or in their
untreateddaughters. Therewas one tumour (1-7 per cent) at the age of 5 months
in an M/NBT mouse, and one (1-2 per cent) at the age of 17 months in an unin-
jected daughter (M/NBT F,) (Table 1).
Reciprocal hybrid strains.-Tumours appeared in all groups of hybrids, the
CN and the reciprocal NC, and the treated M/CN andM/NC groups (Table 1). Of
the total of 99 tumours hybrid mice, only 14 were breeders; in the Simpson
(otherwiseMarsh Buffalo) strain, virgin and breeding females have similar tumour
incidences (Bischoff, 1945 ; Miller and Pybus, 1945).
1. Control hybrid groUP8.
Table I shows the tumour incidences and the ages at death of tumorous and
non-tumorous mice in the various groups. In the 12 generations of CN hybrids
there were 10 mice with breast tumours (1-965 percent) in a total of509 females of
15 months and over (I5 monthsbeing the earhest age at which a tumour was found
in this group), at an average age of 24-9 months (o-
= 4-4) ; the latest tumour
occurred at 30 mo.nths. As shown in TableII, 8 ofthese casesappeared inF, and
F21 where the incidences were 5-6 per cent (3 in 54 F, mice) and 3-9 per cent
(5 in 127 F2 mice) respectively, and the remaining 2 inFg andF,,.
TABLE I.-Incidence of Mammary Tumour8 in Untreated and Methylcholanthrene-
injected Female Mice of Two Inbred Strains and their Reciprocal Hybrids.
Non-tumorous mice.
Number of mice.
t Age at death Age at death
Total in Tumorous mice.. (months). (nionths).
experi- Effective -A-------------% tA
Strain and Generations. ment. number. Number. Per cent. Average. Range. Average. Range.
CBA controls 254 0 0.0
M/CBA injected 51 0 0.0
M/CBA FIL uninjected 168 0 0.0
NBT controls 309 0 0-0 -
M/NBT injected 69 59 1 1-7 5-5 5 5
M/NBT FIL uninjected 81 36 1 2-8 17-0 17-0
CN controls FIL-F12 697 509 10 2-0 24-9 15-0-30- 0 22-9 15 -0-34-0
Ft-Fl2 639 455 7 1-5 22 7 15 -0-26-0 -
F,-F,2 418 267 2 0-7 20-5 15-0-26-0 -
M/CN uninjected F$-F12. 438 356 1 0-3 11-0 11.0 14-9 11-0-25-0
M/CN injected F,-Flo 538 283 18 6-4 17-3 9-0-25-5 14-8 9-0-28-0
NC controls FL-F,,, 575 532 22 4-1 21-1 11-0-29-5 21-8 11-0-36-0
F2-Fl2 517 475 16 3-4 19-3 11-0-26-0 -
Fr-F12 290 258 7 2.1 18-9 13-0-24-0 -
M/NC uninjected F&-FI2 855 450 6 1-3 24-3 21-0-27 0 23-6 21-0-29-0
MINC injected F,-Flo 669 570 42 7- 4 17-1 6-0-28-0 10-8 6-0-31-0
1.NC.
A
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In the 12 generations of NC hybrids (Table 1) there were 22 cases of breast
cancer (4-135 per cent) in a total of 532 females of 11 months and over, at an
average age of 21-1 months (o-
= 4-8). The earliest tumour in this group was
found at 11 months and the latest at 29-5'months. Table II shows'that agairi the
majority of cases appeared in F, and F2 (6 in 57 F, mice or 10-5 per cent, and
in105 F ntice or 5-7 per cent), the remainder being scatteredthrough the other
generations, 3 occurring inF5 (7-9 per cent, in 38 mice).
TABLIF, II.-Incidence of Mammary Tumour8 in Each Generation of CN
and NC Hybrid8.
CN.
A
Number of mice. Tumor'ous mice.
Generation. r A
t -----A.
-I
Total in
experi- Effective
ment. number. No. Percent.
Fl 58 54 3 5-6
F2 145 127 5 3- 9
F3 33 0 0.0
F4 37 28 0 0.0
F5 33 23 0 0.0
F6 29 21 0 0.0
F7 24 16 0 0.0
F,8 38 31 0 0.0
Fg 42 33 1 3-0
Flo 59 37 0 0.0
Fll 66 30 1 3- 3
F12 127 76 0 0.0
r
Number ofmice.
t -A- Total'm
experi- Effective
ment. number.
58 57
109 105
55 54
63 58
42 38
48 43
24 22
50 47
39 33
33 27
26 21
28 27
Tumorous mice.
t A -%
No.
6
6
2
1
3
1
0
1
1
0
1
0
Per cent.
10.5
5- 7
3- 7
1- 7
7- 9
2-3
0.0
2-1
3-0
0-0
4- 8
0.0
Totals :
Fj-F12
'
F2-FI2
-
F5-F12
-
697
639
418
509
455
267
10
7
2
2-0 575 532
1-5 517 475
0- 7 290 258
22
16
7
4-1
3-4
2- 7
The differences of 2-17 per cent in the tumour incidences (twice the standard
error of the difference = 2-12) and of 3-8 months in the average tumour ages (0-d
= 1-7) in the reciprocal hybrids were both statisticaRy significant. The
total NC group therefore had a mammary tumour incidence more than twice that
of the total CN group, and tumours appeared nearly 4 months earher in the NC
mice. In both groups, as shown in Table 1, the non-tumorous mice lived to about
the same age as the tumorous n2ice.
In both groups the tumour incidences were higher in F, than in F2, but not
significantly so. In the preceding paper of this series (Mfller and P us, 1954b) it was pointed out how apossible contamination of someunmjectedF, mice could
have taken place by contact with, or by Ucking, their injected litter-mates.
There was no means of telhng which mice might have been contaminated, nor
whether the amount of carcinogen transferred was always sufficient to induce
neoplasms ; in the case oflung tumours there was good reason to beheve that the
quantity was enough, but in the case offorestomach papillomata it seemed to be
inadequate. In the present instance, since both groups were equally subject to
such possible contamination in F,, a comparison between the incidences in the
reciprocal F, mice would still be valid: in fact, owmg to the smaR numbers, this
difference was not significant, and the difference between therec'i'procalF2tUMoUr658 E. W. MILLER AND F. C. PYBUS
incidences was also not significant. But for purposes of comparison with the
injected groups the incidences in the untreated F, mice must be omitted fromthe
totals for these control groups. Both Tables I and II, therefore, show the total
incidences als'o for F2 to F12 ; the difference between these totals of 7 in 454 CN
mice (1-538 per cent) and 16 in 475 NC mice (3-368 per cent) was not significant
(d
= 1-83, 2 x SE 2-02), but the NC group still had the higher incidence of
spontaneous tumours.
2. Uninjected MICN and MINC groups.
In theM/CN and M/NC groups there were many mice fromF5onwards, as well
as the whole ofFl, and F.21 which were not injected. As shown in Table I the
total incidence of breast cancer in these two groups was very low. In the unin-
jected M/CN rnice (Table III) there was one case of breast cancer (at the age of
II months) in the 82F., femalessurviving to that age, an incidence of 1-2 per cent
in thatgenerationand, as there were no other cases in the group, of 0-281 per cent
in the 356 females ofallgenerationsliving to 11 months and over.
TABLE III.-Incidence of Mammary Tumours in Uninjected MICN and MINC
Hybrids.
M/CN. MINC.
-A A
r
Number of mice. Tumorous m e. Number of mice. Tumorous mice.
e- A
I d, A A A
Generation. Total in Total in
experi- Effective experi- Effective
ment. number. No. Percent. ment. number. No. Percent.
F5 41 38 0 0.0 28 16 0 0.0
F,8 4 3 0 0.0 102 72 0 0.0
F7 19 16 0 0.0 77 46 2 4.3
F8 33 31 0 0.0 42 29 3 10-3
Fg 49 40 0 0-0 34 13 1 7
- 7
Flo 52 45 0 0.0 82 43 0 0-0
Fil 108 82 1 1-2 150 59 0 0.0
F12 132 101 0 0-0 340 172 0 0.0
Total 438 356 1 0-3 855 450 6 1-3
In the uninjected M/NC group (Table III) the earliest tumour was seen at 21
months, and tumours were foundinF7,F. andFg,giving atotal of 6 in 450females
(1-333 per cent) living to 21 months and over, at an averaae a-ae of 24-3 months. 'Cowl qz;;,
There were no tumours in Fil and F12,
In both groups the average age at death of non-tumorous rnice was such that
there was adequate opportunity for the production of tumours, but the MINC
mice lived 9 months Ion er than the MICN. The total tumour incidence in the
uninjectedM/NChybrids was notsignificantlygreater than that in theuninjected
MICN group (d
= 1-052) 2 x SE = 1-213).
Since the naice of these two groups belonged to F,, to F12, a comparison was
made with the corresponding generations of untreated controls CN and NC
(Table I). In the CN hybrids there were 2 tumorous mice in the 267 females
in F5 to F12, an incidence of 0-749 per cent; this is in statistical agreement with
the incidence of 0-281 per cent in the uninjectedM/CN mice. In the NC hybrids
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cent ; this is in statistical agreement with the incidence of 1-333 per cent in the
uninjectedM/NC group.
3. Injected hybrid groups.
In the injected hybrids, compared with the controls, the tumour incidence
was raised and the tumour age lowered in both groups (Table I). In the MICN
groupthere were 18 tumorous mice in 283living to 9 months and over, anincidence
of 6-36 per cent, at an average age of 17-3 months (o-
= 4-5). The earhest
tumour was found at 9 months, the latest at 25-5 months. Table IV shows
that the majority of tumours appeared in the first 2 generations, 4 cases
28 Fl females (14-3 per cent) and 9 in 64F2females (14-1 per cent). Compared with the CN mice (minus Fl), the increase in the tumour incidence
from 1-538 per cent in CN to 6-36 per cent in MICN was significant, (d 4-822,
2 X SE 3-122), as was the lowering of 7-6 months in tumour age (o-,,
= 1-7). In the M/NC group (Table IV) there were 42 tumorous mice in 570 surviving to the age of 6 months and over (7-368 per cent) ; the earliest tumour was seen
at 6 months and the latest at 28 months, the average tumour age being 17-1
months (a-
= 4-1). UnUe the CN, NC and MICN groups, tumour incidence
remained high in all but 2 generations (F. where there were no tumours and F. where the incidence was 3-7 per cent) and varied in the other generations from
6-8 per cent inF, to 12-5 per cent in F. (3 tumours in 24 mice).
TABLE IV.-Incidence, of Mammary Tumours in Each Generation of MICN and
MINC Hybrids.
M/CN.
r A --"%
Number of mice. Tumorous mice.
r A
Total in
experi- Effective
ment. number. No. Per cent.
47 28 4 14-3
134 64 9 14-1
45 35 2 5-7
59 27 0 0.0
58 38 2 5-3
12 8 0 0.0
25 11 0 0.0
53 24 1 4- 2
39 21 0 0.0
66 27 0 0.0
M/NC.
A
r
Number ofmice. Tumorous mice.
r.. A
Total in
experi- Effective
ment. number. No. Per cent.
51 44 3 6-8
122 108 8 7-4
33 27 1 3- 7
107 95 7 7-4
60 48 0 0.0
49 40 3 7- 5
84 77 6 7- 8
31 24 3 12-5
62 48 4 8-3
70 59 7 11.9
Generation.
Fl
.
F2 -
F3 -
F,j
.
F5 -
F6
.
F7 -
F8
.
Fg
.
Flo I
Total . 538 283 18 6-4 669 570 42- 7-4
Compared with the NC group, the lowering of the tumour age by 4 months (from 21-1 to 17-1 months) (o-,, 1-2) and the raising of the incidence from 3-368
per cent in NC (minus F1) to 7-368 per cent in MINC were both significant (d 4-0) 2 x SE 2.746).
Comparing the two groups ofinjectedhybrids, the difference in average tumour
ages of 0-2 months was not significant. The difference in tumour incidences of
per cent was ralso not significant. It appears that the large dose ofmethyl- cholanthrene had wiped out the differences in tumour age and incidence seen
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the untreated control hybricls. A similar obhteration (of a sex-difference) was
describedbyStrong (1943) in connection withinducedlung-tumours.
A comparison was made of the incidences in the early generations ofinjected
and control hybrids. In F,, the difference of 8-7 per cent between Af/CN (4
tumour mice in 28, or 14-3 percent) and CN (3 in 54, or 5-6 percent) was notsigni-
fican't, and neither was the difference of 3-7 per cent between M/NC (3 tumorous
mice in 44, or 6-8 per cent) and NC (6 in 57, or 10-5 per cent) ; it wiR be noticed
that in the first case the injected and in the second case the uninjected animals
had the higher incidence. In the reciprocal F2groups, the injected mice had the
higher incidence in both cases: the difference of 10-2 per cent between M/CN
(9 tumorous mice in 64, or 14-1 per cent) and CN (5 in 127, or 3-9 per cent) was
significant, (d
= 10-2, 2 x SE = 9-4), but the difference of 1-7 per cent between
M/NC (8 tumorous mice in,108, or 7-4 per cent) and NC (6 in 105, or 5-7 percent)
was not significant.
It was expla"medpreviously (Mfller and Pybus, 1954a and 1954b) that the first
hybrid generation was the result of a series of crosses between different sub-lines
of the 2 inbred parent strains and there was the possibility ofgenetic divergence
between these sub-lines due to undisclosed mutations within them. The great
majority ofM/NC mice came from the cross between Sub-lines C and P. Offspring
from the same cross formedpart ofthe NC group, and their incidence ofmammary
tumours was analysed: in the 24 F, mice there were 3 with tumours (12-5 per
cent), an incidence higherthan, but not significantly different from, that ofMINC
F, ; in the 47 F2mice there were 2 with tumours (4-3 per cent), giving a difference
of 3-1 per cent compared withMINCF2 (7-4 per cent) which, althoughlarger than
the differ'ence of 1-7 per cent obtained between M/NC F2 and the whole NC F21
was stffl not significant, possibly owing to the small numbers available, but the
trend supported the result obtained in the F2 of the reciprocal hybrid group.
In the remainder of this section of the NC group there were 2 tumorous mice in
the 12 in F. but none in later generations, giving a total of 7 tumorous mice
i
120 of II months'and over (5-8 per cent) inF, to F12or, omittingF,, 4 in 96 mice
(4-2 per cent). On account of the small numbers involved, both these incidences
are in agreement both with the incidence in the remainder of the NC group, with
or without Fl, and also with the total incidence- in the M/NC group.
The Site of Tumours.
The fact that the majority of breast tumours in injected mice appeared at a
considerablylater age than themajority oftumours (ofothertypes) induced at the
site of injection suggests that the induction of the former was not purely a
direct effect of the carcinogen on the tissues concerned. This is borne out by
an analysis ofthe sites of the mammary tumours.
In the injectedhybrids, most of the induced local subcutaneous tumours were
sarcomata, but, amongst those exaniined histologically, 12 proved to be mam-
mary carcinomata. Three of the mice with these local mammary tumours also
had r-emote breast tumours, 2 on theright side and one on the left. (A mammary
carcinoma in the third or fourth glands on the right side was considered to be at
the site ofinjection, which was theright flank oftheanimal; tumours in Glands 1,
2 and 5 on theright side were considered to be remote, as were all those on the left
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There were 60 cases ofbreasttumours,including these 12, amongst theinjected
hybrids. Apart from those with tumours at the site ofinjection, 27 had tumours
on the left side, 15 on theright side and 6 bilateral. This is to be compared with
the controlhybrids (CN, NC, uninjectedMICN anduninjectedM/NQ where there
were 17 cases on the left side, 17 on the right side and 4 bflateral (plus 1 at site
unrecorded) (Table V). These distributions do not differ significantly from one
another. Had the action of the carcinogen been a direct one on the mammary
tissues, a preponderance of tumours on the right side might have been expected,
being nearer the site of administration of the carcinogen; tumours arising on the
left side could then have been ascribed to direct subcutaneous seepage of the
chemical.
TABLF, V.-Di8tribution of Mammary Tumoum according to Site in Injected and
Control Mice.
Numbers of tumorous mice.
M/CN. M/NC.
r
Location. CN. injected. uninjected. NC. miected. uninjected.
Site ofinjection 1 11
Right side 8 7 0 7 8(2) 2
Left side 2 9 0 11 18(3) 4
Bilateral 0 1 1 3 5 0
Totals . 10 18 1 21(l) 42 6
(1) = plus 1 case site not recorded.
(2) = plus 2 mice with tumours also at site of injection.
(3) = plus 1 mouse with tumour also at site ofinjection.
HidOlOgy.
All the usual types of mammary carcinoma were observed in the present
series of tumours. Some (about one-third) of the spontaneous tumours, usuaRy
in older animals, were mainly ofthe scirrhous type, and squamous metaplasia was
seen in a few spontaneous tumours in mice of various ages, the youngest being
11 months old. The proportion of scirrhous tumours was not increased in the
injected mice, but there were several instances of mixed sarcoma-carcinomata,
a type not seen in the spontaneous tumours ; 6 ofthese were remote tumours, the
other 2 being at site of injection. Evidence of lactation was seen in 3 induced
tumours and in 1 spontaneous tumour. Tumours showing squamous metaplasia
were very much more frequent in the treated mice, 13 being seen, compared with
3 in spontaneous cases, the youngest injected mouse to show this type being only
6 months old. In all these respects, the present series oftumours agreed with the
findings of Andervont and Dunn (1950).
DISCUSSION.
The parent strains used in this investigation were beheved to lack the irnilk
factor, but were known to be susceptible to its influence. The NBT strain was
derived by -selection andinbreeding from the Simpson Strain 3 (Pybus and MiRer,662 E. W. MILLER AND F. C. PYBUS
1938) which is know-n to have possessed the milk factor (Miller and Pybus, 1945).
When the Simpson strain came to this laboratory, it was known to have passed
through aphase ofcage-breeding ; therefore, in order to obtain ahomozygous pure
line as quickly as possible, it became customary to mate the mice (brother to
sister) when quite young, to take only two litters as a rule from each breeding
female, and to breed from the first ofthese. From what is now known about the
milk factor (Bittner, 1942 ; Miihlbock, 1950) it seems that no better method could
have been devised either forgetting rid ofthatagent or at least forkeeping it in an
attenuated state. This may be the explanation of the progressive decrease in
mammary tumour incidence in later generations of the Simpson strain, as also
in its derivative NBT strain. It is possible therefore that the NBT mice were not
absolutely agent-free ; the agent might have been present in a very attenuated
form and capable of showing itself only in a very favourable environment,
produced (as suggested by Dmochowski, 1953) by a change in the genetic
constitution ofthe animals.
The CBA strain was bred in this laboratoryby a similar method. This strain
may either lack the agent completely or possess it in a still more attenuated state.
Cases of breast cancer have never been at all frequent in the strain and in recent
generations havedisappearedcompletely. Recent work on the presence ofhyper-
plastic nodules in the mammary glands (Mffler and Pybus, 1952) confirms the
absence or very lowpotency oftheagent.
The total incidence of breast cancer in the 12 generations of the reciprocal
hybridsbetween these 2 inbred strains washigher than that in eitherparentstrain,
and the total incidence in the NC group was significantly greater than that in the
CN group. The crucial test for the effective presence ofthe milk factor would have
been a comparison of the F, incidences but, owing to the unfortunate possibility
ofcontamination of some ofthe untreatedF,, mice ofboth crossesby contactwith,
or by licking their injected litter-mates (as already described (Mfller and Pybus,
1954b)), this comparison is valueless from this point of view (since some of the
tumours might have been induced by the carcinogen), although both groups ofF,
were equally subject to the contamination. In fact the F, tumour incidences of
5
-6per cent in CNand 10-5per cent inNC do not differsignificantly; asthe number
of cases of breast cancer were so few in each generation, quite large differences
in percentage incidence are not statistically significant. The question of the
possibler'ole ofthe milkfactorinthepresent work must therefore remain open.
The evidence for the transfer ofenough methylcholanthrene to the untreated
F, mice to induce mammary cancer, although not so striking as in the case oflung
tumours. (Afiller and Pybus, 1954b), is convincing. When the total tumour inci-
dences in thecorrespondinginjected and controlreciprocalhybrids werecompared,
it wasfoundthattheincidence wasraisedandthetumourageloweredinthetreated
mice by amounts which were statistically significant. But there was no signifi-
cant difference between the tumour incidences in the CN and M/CN F, mice, or
betweenthe NC andMINCF, mice. Tumour incidences in theinjectedF2animals
werehigherthanthoseinthecorrespondinguntreatedF2mice,althoughsignificantly
soonly in the M/CN, compared with the CN, hybrids. In both groups of control
hybrids, tumour incidences were higher inF, than inF2although not significantly
so. Thegeneticvariability ofF2and latergenerations makes theinterpretation of
these resultsdifficult, especially withrelatively smallnumbers..
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by direct and remote application. Bonser (1940) obtained local mammary
tumoursby subcutaneous injection of this carcinogen in 2 low-incidence strains,
and Orr(I943,1946. 1951) was abletoinducetumoursremotelybyadministration of
the carcinogen intranasally and to the surface ofthe skin. Andervont and Dunn
(1950) obtained mammary cancer in agent-free DBAf/2 temales by rotated percu-
taneous applications of methylcholanthrene, and later (Andervont and Dunn,
1953) reported the production of mammary tumours in the same strainbygiving
a high dose of the same carcinogen by stomach tube. In their earlier work
(Andervont andDunn, 1950)they showed that whereas the smaner dosesproduced
more mammary tumours than leukaemia, the reverse was the case for the largest dose. Strong and Williams (1941) reported onl 3 cases of remote induction y
compared with 42 at the site ofinjection, but the proportion of-remote tumours
increased later, and Strong (1945) stated that he had raised the incidence of
mammary carcinoma from sporadic cases to a steady 60 per cent in his NHO
strain as a result of the previous long-continued series ofinjections.
No evidence was obtained from the present experiment that the effect of
methylcholanthrene in enhancing the tumour incidence was transmitted to the
uninjected descendants of the injected mice. No cases ofbreast cancer appeared
in the verylarge F.2oftheM/NC group where there were 340 uninjected females,
ofwhich 172 were
" effective," i.e. alive at 21 months (lowest tumour age in this
group), and descended from 10 generations of injected mice. Strong's (1945)
hypothesis of agenetic mutation induced by the carcinogen cannot be supported by the results of the present work.
Thequestion ofhormonal stimulation does not appear to enter intothedevelop-
ment of the mammary tumours obtained in the hybrids; only 14 of the 99 mice
with breast cancer were breeders. Hormonal stimulation neverplayed adominant
part in the origin of mammary carcinoma in the Simpson mice, where it has
been shown (Miller and Pybus, 1945 ; Bischoff, 1945) that the incidence in
breeder and virgin mice is practically the same, with a slightly higher incidence
in the latter. Twelve of the 14 tumour-bearing breeders were injected animals.
Kirschbaum et al. (1944) found that the percutaneous application of methyl- cholanthrene accelerated the appearance of mammary tumours in breeding females of a high breast cancer strain, but were unable to state definitely the
effect on virgins of the strain.
Of the three predisposing factors for mammary carcinoma there remains that
of the inheritance of a genetic susceptibility. The incidence of spontaneous
tumours in the reciprocal hybrids was higher than that in either parent strain at
the time ofthe experiment and was ofthe same order as that obtained by Ander-
vont and Du'nn (1948) (17 in 359 mice) for all theirhybrids between strains known
to be agent-free. Andervont and Dunn (1948) concluded that the occurrence of
tumours in a small number oftheirhybrids was evidence that the milk agent may
not be essential for the production of all mouse mammary tumours, and that
inherited tendencies together with hormonal stimulation were predominating influences in the origin of their tumours. The tumours in their experiment, like
those in thepresentinstance, arose at a late age, the averagesvarying from 21 to 28
months.
In the present investigation no breast cancer mouse in either cross had a
tumorous mother, but there were several instances of 2 sisters with spontaneous
tumours, and a study of the heredity charts does suggest the presence of some664 E. W. MILLER AND F. C. PYBUS
inherited factor or factors. This was especially so in one sub-line of the NC
hybrids : 2 F, sisters were mated with their brother, one pair producing 2
tumorousF2daughters in atotal of7, after which this line wasdiscontinued: from
theotherpairingthere was one tumorousF2female (in I1) ; there were no tumours
in the next 2 generations (of I1 and 12 females) but in F5there were 2 cancerous
sisters in I1 females ; inF6 (6 mice) andF7 (6 mice) there were no tumours, but in
F8 (IO mice) there was one tumorous female; there was again a gap of 2 tumour-
free generations (of 4 and 6 mice),'but inFl, (10 mice) there was one tumour, and
in F12 there was none in 9 mice. A-nother F, brother-sister mating in the same
sub-line produced one tumour in 8 F2 females, but this line was not continued;
there were also 2 F, rm'ce in this sub-line which had tumours, one of these mice
having been injected and the other a suspect for contamination. Apart from the
induced tumour which appeared at 14 months and one in F5 at 15 months, all
these tumours were seen at ages of from 17 to 29 months. Omitting the F,
cases, the incidence in this sub-line was therefore 7-2 per cent (8 tumours in 111
mice). The parents of this sub-line belonged to Sub-line B of NBT and to Sub-
line R ofCBA (Mfller and Pybus, 1954a). The same B x R cross contributed to
the first 5 generations ofMINC hybrids ; there were in this section 8 tumour mice
(I in Fl, 4inF2,3 in F4) at ages offrom II to 23 months in a total of 96
i 'ected
females, and one in 19 unmjected F5mice ; the incidence was 8
-3 per cent in the
. .ected mice. Mi
In the injected reciprocal hybrid groups the majority of tumours seemed to
occur at random. In one litter there were as many as 3 cases of breast cancer,
2 on the right side and 1 bilateral, but otherwise, apart from the sub-line men-
tioned above, there was Ettle evidence ofdefinitefamilysusceptibility.
On the whole, however, there is some reason to suppose that inherited tenden-
cies played some part in the o
i i of mammary, carcinoma in the present experi-
ment, and that hybridisation was responsible for the increased tumour incidence
compared with the parent strains. In the CN group this increase was confined
mainly to the first 2 generations, of which F, must be disregarded, but in the NC
hybrids the increased incidence persisted in some degree to F3L1. The NC hybricls
were more susceptible than the CN over the whole 12 generations as measured
both by total tumour incidence and by average tumour age. It is probable that
genetic divergence between the two sets of hybrids, such as has already been
seen to occur for lung tumours (Mfller and Pybus, 1954b), could account for this
difference and, in the absence of any definite proof from the F, mice, together
with the advanced ages at which most of the spontaneous tumours appeared, it
seems improbable that the milk factor was present.
Although genetic variability comphcates the interpretation of the data,
there seems to be good evidence, supported by the results ofprevious workers in
this field, that the methylcholanthrene treatment increased the incidence of
mammary tumours and induced them earlier, and the effect does not appear to be
due entirely to direct action of the carcinogen on the mammary tissues, since
tumours were found more often on the left side than on the right. An explana-
tion ofthe effect seems to beprovidedby the recent work ofJull(1952), from which
it appears that methyleholanthrene has a progesterone-like effect on mammary
tissue in stimulating the acinar development, which is a precursor of mammary
cancer, although Orr (1951) considered that the methylcholanthrene-induced
tumours themselves were derived from the duct epithehum.MAMMARY CARCINOMA IN MICE 665
SUMMARY.
1. The incidence of spontaneous mammary carcinoma was increased by
hybridisation between the two low-incidence inbred strains of mice, CBA and
NBT.
2. One subcutaneous injection of I mg. methylcholanthrene per mouse raised
the incidence and lowered the age of mammary carcinoma in both groups of
reciprocal hybrids over 10 generations ofinbreeding. This effect was not carried
over into theunmjected descendants ofinjected mice.
3. Mammary tumours occurred more frequently on the left side than on the
right side oftheinjected mice, theinjection being made into the right flank.
4. Theinterpretation ofthese results is discussed.
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ofthis paper.
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